These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12968092)

  • 1. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-2003. A 51-year-old premenopausal woman with newly diagnosed breast cancer and a strong family history of breast cancer.
    Ryan PD; Haber DA; Shannon KM; Smith BL; Fan MJ
    N Engl J Med; 2003 Sep; 349(11):1076-82. PubMed ID: 12968092
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery.
    Zografos GC; Roukos DH
    Ann Surg Oncol; 2010 Mar; 17(3):939; author reply 940. PubMed ID: 19937131
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
    Garcia-Etienne CA; Barile M; Gentilini OD; Botteri E; Rotmensz N; Sagona A; Farante G; Galimberti V; Luini A; Veronesi P; Bonanni B
    Ann Surg Oncol; 2009 Dec; 16(12):3380-7. PubMed ID: 19649554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Must we always hunt for a sentinel node?
    Gentilini O
    Breast; 2010 Feb; 19(1):13. PubMed ID: 20005714
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy in elderly breast cancer patients.
    Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
    Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer.
    Diez O; Gutiérrez-Enríquez S; Mediano C; Masas M; Saura C; Gadea N; Balmaña J
    Breast Cancer Res Treat; 2010 May; 121(1):221-5. PubMed ID: 19649703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Routine sentinel node detection in breast cancer. Experience of the Curie Institute].
    Delahaye S; Benamor M; Nos C; Vincent-Salomon A; El Khoury C; Doridot V; Sigal-Zafrani B; Clough KB;
    Bull Cancer; 2004; 91(7-8):641-7. PubMed ID: 15381455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Foulkes WD; Kim-Sing C; Ainsworth P; Rosen B; Armel S; Poll A; Eisen A; Gilchrist D; Chudley A; Ghadirian P; Maugard C; Lemire EG; Sun P; Narod SA
    Clin Genet; 2008 May; 73(5):474-9. PubMed ID: 18341607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
    Tan JC; McCready DR; Easson AM; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast-conserving surgery in breast cancer].
    Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
    G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of breast cancer.
    Vazquez B; Rousseau D; Hurd TC
    Semin Oncol; 2007 Jun; 34(3):234-40. PubMed ID: 17560985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.